Child-Pugh
Showing 26 - 50 of 5,883
Carcinoma, Hepatocellular Trial in China, Korea, Republic of, Taiwan (Tepotinib 300 mg, Tepotinib 500 mg, Tepotinib 1000 mg)
Completed
- Carcinoma, Hepatocellular
- Tepotinib 300 mg
- +4 more
-
Beijing, Beijing, China
- +42 more
Aug 22, 2022
Heart Failure Trial in Lübeck (Vericiguat (BAY1021189))
Completed
- Heart Failure
- Vericiguat (BAY1021189)
-
Lübeck, Germany(unnamed)
Jan 21, 2021
Hepatocellular Carcinoma Trial in Mainz (Cabozantinib)
Recruiting
- Hepatocellular Carcinoma
-
Mainz, GermanyDepartment of Internal Medicine I, Johannes Gutenberg University
Sep 30, 2020
Liver Cancer Trial in Dijon (pravastatin sodium, sorafenib tosylate)
Completed
- Liver Cancer
- pravastatin sodium
- sorafenib tosylate
-
Dijon, FranceHopital Du Bocage
Mar 27, 2020
Assessment of Severity of Liver Disease Before Surgery
Not yet recruiting
- Cirrhosis, Liver
- abdominal surgeries
- (no location specified)
Aug 14, 2022
Healthy Volunteers, Hepatic Impairment of Moderate Child Pugh Category Trial in Gières, Balatonfüred, Miskolc (MD1003)
Terminated
- Healthy Volunteers
- Hepatic Impairment of Moderate Child Pugh Category
-
Gières, France
- +2 more
May 11, 2020
HVPG and ICG-R15 in Short- and Medium-term Results of Surgery of
Recruiting
- Hepatocellular Carcinoma
- Hepatic venous-portal gradient (HVPG) measurement
-
Napoli, ItalyFederico II University Hospital
Mar 24, 2023
Carcinoma, Hepatocellular, Liver Cancer, Liver Cirrhosis Trial in United States (GALAD, Liver Ultrasound with or without AFP)
Not yet recruiting
- Carcinoma, Hepatocellular
- +3 more
- GALAD
- Liver Ultrasound with or without AFP
-
Los Angeles, California
- +9 more
Oct 18, 2023
BCLC Stage C HCC, CP-B Liver Cirrhosis Trial in Amsterdam (Sorafenib, Midazolam clearance test, CYP cocktail clearance test)
Terminated
- BCLC Stage C HCC
- CP-B Liver Cirrhosis
- Sorafenib
- +2 more
-
Amsterdam, NetherlandsAcademic Medical Center
Aug 20, 2019
Liver Cirrhosis Trial in Bunkyo-Ku (Foscenvivint)
Not yet recruiting
- Liver Cirrhosis
-
Bunkyo-Ku, Tokyo, JapanTokyo Metropolitan Komagome Hospital
Nov 29, 2023
Pharmacology, Clinical Trial in Kiel (Neladenoson bialanate (BAY 1067197))
Terminated
- Pharmacology, Clinical
- Neladenoson bialanate (BAY 1067197)
-
Kiel, Schleswig-Holstein, GermanyCRS Clinical-Research-Services Kiel GmbH
Mar 25, 2020
Clinical Pharmacology Trial in Kiel (Riociguat (Adempas, BAY 63-2521))
Completed
- Clinical Pharmacology
- Riociguat (Adempas, BAY 63-2521)
-
Kiel, Schleswig-Holstein, Germany(unnamed)
Apr 25, 2020
Muscle Atrophy Trial in Cairo (BCAA, home-based graded exercise program)
Completed
- Muscle Atrophy
- BCAA
- home-based graded exercise program
-
Cairo, EgyptKasr Aliny School of Medicine
Oct 12, 2023
Alcoholic or Viral C Compensated Cirrhosis Trial in Caen (G20210A prothrombin gene mutation and Factor 5 Leiden mutation)
Completed
- Alcoholic or Viral C Compensated Cirrhosis
- G20210A prothrombin gene mutation and Factor 5 Leiden mutation
-
Caen, FranceCHU de CAEN
Jan 22, 2020
Hepatic Impairment Trial in Orlando (TD-4208)
Completed
- Hepatic Impairment
-
Orlando, FloridaOrlando Clinical Research Center (OCRD)
Feb 22, 2022
Decompensated Cirrhosis Trial in Shanghai (Low-dose of Rifaximin, Conventional dose of Rifaximin)
Recruiting
- Decompensated Cirrhosis
- Low-dose of Rifaximin
- Conventional dose of Rifaximin
-
Shanghai, ChinaShanghai East Hospital
May 16, 2023